A highly potent and stable pan-coronavirus fusion inhibitor as a candidate prophylactic and therapeutic for COVID-19 and other coronavirus diseases

• Main Authors: Jie Zhou (Author), Wei Xu (Author), Zezhong Liu (Author), Chao Wang (Author), Shuai Xia (Author), Qiaoshuai Lan (Author), Yanxing Cai (Author), Shan Su (Author), Jing Pu (Author), Lixiao Xing (Author), Youhua Xie (Author), Lu Lu (Author), Shibo Jiang (Author), Qian Wang (Author)
• Format: Book
• Published: Elsevier, 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The development of broad-spectrum antivirals against human coronaviruses (HCoVs) is critical to combat the current coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its variants, as well as future outbreaks of emerging CoVs. We ha...